Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Jefferies Financial
JEF
HK Stock MarketDetailed Quotes
01515 CR MEDICAL
- 3.670
- +0.010+0.27%
Market Closed May 2 16:08 CST
4.76BMarket Cap7.79P/E (TTM)
3.670High3.600Low1.45MVolume3.660Open3.660Pre Close5.29MTurnover0.11%Turnover Ratio7.79P/E (Static)1.30BShares5.01052wk High0.71P/B4.76BFloat Cap3.00552wk Low0.12Dividend TTM1.30BShs Float16.271Historical High0.066Dividend LFY1.91%Amplitude2.584Historical Low3.641Avg Price500Lot Size3.30%Div YieldTTM1.80%Div Yield LFY
CR MEDICAL Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 70.14%838.67M | ---- | 16.55%492.92M | ---- | 56.37%422.94M | ---- | -35.32%270.48M | ---- | -22.74%418.19M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 83.35%-14.21M | ---- | 8.59%-85.33M | ---- | -20.54%-93.35M | ---- | 3.11%-77.45M | ---- | -23.00%-79.93M | ---- |
| Dividend (income)- adjustment | 7.28%-3.59M | ---- | -19.14%-3.87M | ---- | -16.24%-3.25M | ---- | -6.76%-2.8M | ---- | -398.67%-2.62M | ---- |
| Attributable subsidiary (profit) loss | -8.62%-98.6M | ---- | -3.08%-90.78M | ---- | -5.40%-88.07M | ---- | -138.94%-83.55M | ---- | -652.65%-34.97M | ---- |
| Impairment and provisions: | -91.58%40.56M | ---- | 252.24%481.37M | ---- | -61.54%136.66M | ---- | 1,410.26%355.29M | ---- | 1,391.76%23.53M | ---- |
| -Impairment of property, plant and equipment (reversal) | -84.75%32.15M | ---- | 41,231.18%210.79M | ---- | --510K | ---- | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | 122.69%481K | ---- | 1,036.84%216K | ---- | --19K | ---- | ---- | ---- | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | 30.18%141.02M | ---- | --108.32M | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | -93.88%7.92M | ---- | 365.18%129.35M | ---- | -92.17%27.81M | ---- | 1,410.26%355.29M | ---- | 1,391.76%23.53M | ---- |
| Revaluation surplus: | -13.87%14.23M | ---- | 393.48%16.52M | ---- | -120.53%-5.63M | ---- | 9.06%27.42M | ---- | 86.35%25.14M | ---- |
| -Other fair value changes | -13.87%14.23M | ---- | 393.48%16.52M | ---- | -120.53%-5.63M | ---- | 9.06%27.42M | ---- | 86.35%25.14M | ---- |
| Asset sale loss (gain): | 369.06%11.19M | ---- | 144.43%2.39M | ---- | ---5.37M | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---5.68M | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 369.06%11.19M | ---- | 671.84%2.39M | ---- | --309K | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | 1.32%618.9M | ---- | 25.59%610.86M | ---- | 165.97%486.41M | ---- | 61.29%182.88M | ---- | 78.15%113.38M | ---- |
| -Amortization of intangible assets | -49.22%3.31M | ---- | -2.60%6.52M | ---- | 0.01%6.69M | ---- | -15.25%6.69M | ---- | -57.88%7.9M | ---- |
| -Other depreciation and amortization | 18.75%-12.41M | ---- | 35.07%-15.28M | ---- | ---23.53M | ---- | ---- | ---- | ---- | ---- |
| Financial expense | -42.90%75.28M | ---- | 85.30%131.84M | ---- | 298.95%71.15M | ---- | 2.55%17.83M | ---- | 2.65%17.39M | ---- |
| Exchange Loss (gain) | -98.47%1.19M | ---- | -51.10%77.69M | ---- | 692.87%158.88M | ---- | 39.53%-26.8M | ---- | -464.48%-44.31M | ---- |
| Special items | ---- | ---- | ---- | ---- | -81.02%1.92M | ---- | 454.24%10.11M | ---- | -121.62%-2.85M | ---- |
| Adjustment items | 18.75%-12.41M | ---- | 35.07%-15.28M | ---- | ---23.53M | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | -9.09%1.47B | ---- | 52.85%1.62B | ---- | 57.22%1.06B | ---- | 55.54%673.41M | ---- | -26.99%432.94M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -100.10%-67K | ---- | 476.00%65.18M | ---- | -8,316.11%-17.34M | ---- | 100.91%211K | ---- | -247.77%-23.29M | ---- |
| Accounts receivable (increase)decrease | 188.54%106.5M | ---- | -226.34%-120.28M | ---- | -30.77%95.2M | ---- | 48.30%137.52M | ---- | 174.59%92.73M | ---- |
| Accounts payable increase (decrease) | 85.33%-32.79M | ---- | 18.41%-223.47M | ---- | -153.48%-273.91M | ---- | -144.84%-108.06M | ---- | 517.85%240.97M | ---- |
| prepayments (increase)decrease | -1,075.89%-40.97M | ---- | -95.82%4.2M | ---- | -24.10%100.45M | ---- | 17,023.27%132.34M | ---- | -173.22%-782K | ---- |
| Special items for working capital changes | 76.34%-13.28M | ---- | -819.66%-56.15M | ---- | 160.75%7.8M | ---- | -25.69%-12.84M | ---- | -284.71%-10.22M | ---- |
| Cash from business operations | 14.39%1.49B | ---- | 34.40%1.31B | ---- | 18.04%970.97M | ---- | 12.32%822.58M | ---- | 40.35%732.35M | ---- |
| Other taxs | -44.24%-235.69M | ---- | -13.60%-163.4M | ---- | -5.77%-143.84M | ---- | -38.38%-135.99M | ---- | 40.03%-98.27M | ---- |
| Interest received - operating | -75.43%13.15M | ---- | 46.78%53.51M | ---- | 52.90%36.46M | ---- | 148.04%23.84M | ---- | 18.33%9.61M | ---- |
| Special items of business | ---- | -6.05%507.76M | ---- | 459.47%540.44M | ---- | -24.18%96.6M | ---- | -43.40%127.41M | ---- | 3,067.93%225.11M |
| Net cash from operations | 6.29%1.27B | -6.05%507.76M | 38.39%1.2B | 459.47%540.44M | 21.56%863.59M | -24.18%96.6M | 10.37%710.43M | -43.40%127.41M | 75.85%643.69M | 3,067.93%225.11M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | -96.13%3.59M | -7.28%3.59M | 1,990.00%92.75M | 19.14%3.87M | 58.78%4.44M | 16.24%3.25M | 6.76%2.8M | 6.76%2.8M | 398.67%2.62M | 398.67%2.62M |
| Loan receivable (increase) decrease | 434.33%39.48M | 45.94%3.49M | -40.84%7.39M | -35.23%2.39M | 11.63%12.49M | 54.46%3.69M | -41.87%11.19M | -47.57%2.39M | 113.32%19.25M | 214.00%4.55M |
| Decrease in deposits (increase) | -26.62%-32.17M | -386.13%-9.49M | -838.55%-25.41M | 369.59%3.32M | -73.25%3.44M | -107.06%-1.23M | 173.85%12.86M | --17.42M | ---17.42M | ---- |
| Sale of fixed assets | -99.84%89K | -33.99%5.23M | 797.10%54.98M | 104.70%7.93M | 192.41%6.13M | 86.60%3.87M | -71.67%2.1M | 177.78%2.08M | 99.43%7.4M | 105.79%747K |
| Purchase of fixed assets | -15.82%-563.69M | -28.24%-248.39M | -4.38%-486.68M | -78.22%-193.69M | -134.98%-466.28M | -46.22%-108.68M | 5.30%-198.43M | -328.43%-74.33M | -476.23%-209.55M | -85.00%-17.35M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | -260.30%-28.82M | ---- | ---8M | ---- |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | --5K | --50K | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | -2,266.56%-3.77B | ---- | 126.70%173.92M | 120.25%173.92M | -656.53%-651.28M | -832.63%-858.76M | 39,108.67%117.03M | --117.22M |
| Recovery of cash from investments | -95.67%154M | -97.92%55M | -25.35%3.56B | 28.47%2.64B | 12.02%4.76B | 34.03%2.06B | -38.09%4.25B | -59.95%1.53B | 18.42%6.87B | 41.40%3.83B |
| Cash on investment | 94.26%-154M | 97.82%-55M | 38.76%-2.68B | -18.19%-2.53B | 18.35%-4.38B | 25.15%-2.14B | 20.78%-5.37B | 40.30%-2.86B | -19.13%-6.77B | -75.83%-4.78B |
| Other items in the investment business | -98.74%7.98M | -103.43%-15.71M | 203.48%630.72M | 3,626.31%457.93M | -2,258.13%-609.5M | 8.00%12.29M | -49.34%28.24M | 9.20%11.38M | -17.90%55.75M | -76.55%10.42M |
| Net cash from investment operations | 79.23%-544.73M | -165.53%-261.29M | -430.77%-2.62B | 5,417.64%398.71M | 74.48%-494.02M | 100.33%7.23M | -3,307.23%-1.94B | -166.31%-2.22B | -61.61%60.37M | -10,833.53%-832.6M |
| Net cash before financing | 150.84%725.54M | -73.75%246.48M | -486.12%-1.43B | 804.55%939.14M | 130.15%369.57M | 104.97%103.82M | -274.08%-1.23B | -244.03%-2.09B | 34.54%704.05M | -4,187.24%-607.49M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -68.95%1.72B | -41.22%1.14B | -35.52%5.55B | -55.85%1.94B | 41.85%8.61B | 47.96%4.39B | 1,233.95%6.07B | 2,139.09%2.97B | 386.18%455.24M | 1,421.75%132.59M |
| Refund | 57.51%-2.45B | 32.41%-1.28B | 33.03%-5.77B | 56.98%-1.9B | -69.39%-8.62B | -122.59%-4.41B | -1,513.32%-5.09B | ---1.98B | -1,738.65%-315.44M | ---- |
| Interest paid - financing | 45.21%-63.7M | 43.32%-30.88M | -106.16%-116.27M | -302.93%-54.49M | -185.20%-56.4M | -65.06%-13.52M | -39.06%-19.77M | 11.78%-8.19M | 15.52%-14.22M | -86.82%-9.29M |
| Dividends paid - financing | -177.78%-154.27M | ---- | 57.33%-55.53M | -2,085.82%-11.87M | -30.20%-130.14M | 99.40%-543K | 20.49%-99.96M | 21.34%-91.08M | 11.72%-125.73M | -958.89%-115.78M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | -65.46%544K | ---- | 1.29%1.58M | -24.03%980K |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---474K | ---- | ---- | -345.42%-724K | -100.30%-127K | -99.27%295K |
| Net cash from financing operations | -125.31%-984.8M | -426.70%-192.27M | -95.40%-437.08M | 17.57%-36.5M | -126.44%-223.69M | -105.03%-44.29M | 11,559.71%845.96M | 11,387.69%879.84M | 81.98%-7.38M | -55.44%7.66M |
| Effect of rate | 251.77%496K | -73.78%183K | -94.84%141K | -60.00%698K | 16.84%2.73M | 139.91%1.75M | 253.85%2.34M | -461.02%-4.37M | -441.28%-1.52M | 256.87%1.21M |
| Net Cash | 86.09%-259.26M | -93.99%54.21M | -1,377.84%-1.86B | 1,416.10%902.64M | 138.42%145.88M | 104.92%59.54M | -154.50%-379.66M | -101.74%-1.21B | 44.44%696.67M | -1,971.48%-599.83M |
| Begining period cash | -60.13%1.24B | -60.13%1.24B | 5.04%3.1B | 5.04%3.1B | 9.26%2.95B | 9.26%2.95B | 34.65%2.7B | 34.65%2.7B | 31.63%2.01B | 31.63%2.01B |
| Cash at the end | -20.93%977.33M | -67.76%1.29B | -60.13%1.24B | 32.88%4B | 33.39%3.1B | 102.61%3.01B | -13.97%2.32B | 5.63%1.49B | 34.65%2.7B | -9.51%1.41B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | KPMG | -- | KPMG | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts